Skip to main content





Despite the incredible work of the oncology community across Europe, cancer remains the second leading cause of premature death in this region.1,2

At Janssen, we fiercely believe cancer is a challenge we can collectively overcome, and our ultimate aim is to make a cancer a manageable, even curable, condition.

We know that receiving a cancer diagnosis can be overwhelming and sparks fear. We are striving to change this, so that one day the words “you have cancer” will be less terrifying for patients to hear and less distressing for healthcare professionals to say and act upon. 


Our Work in Oncology

Every cancer is different, each possessing unique challenges along the way.We are working to identify some of these challenges and focus precisely on the areas where we can make the most meaningful difference for people living with cancer, and the wider oncology community. To do this, we consistently integrate patients' perspectives into everything we do.


Disease areas of focus

Our Disease Areas of Focus

Haematological Malignancies

Multiple myeloma is a blood cancer that arises from the plasma cells in the bone marrow.4 It is often described as being a very individual cancer.5 Unlike many cancers, myeloma does not exist as a lump or tumour.4 It can affect multiple places in the body where bone marrow is normally active in an adult, such as in the bones of the spine, skull and pelvis.4 At any one time there are around 24,000 people living with myeloma in the UK.4

Chronic lymphocytic leukaemia (CLL) is a type of blood cancer in which the bone marrow produces too many lymphocytes, a type of white blood cell.6 The causes of CLL are unclear; however it is the most common type of leukaemia in adults, around 3,800 people are diagnosed with CLL each year in the UK.6,7

Mantle cell lymphoma (MCL) is typically an aggressive, rare form of non-Hodgkin lymphoma (NHL) that develops from abnormal B lymphocytes. It is called ‘mantle cell’ because the abnormal B lymphocytes come from an area called the ‘mantle zone’ in lymph nodes (glands).8 Around 600 people are diagnosed with mantle cell lymphoma each year in the UK.8

Waldenström macroglobulinemia (WM) – is a type of non-Hodgkin lymphoma in which a certain type of white blood cell – called B-cells – develops incorrectly.9 Although rare, there are around 4,000 people living with WM in the UK.9

Solid Tumour Malignancies

Prostate Cancer is the most common cancer in men and can develop when cells in the prostate grow in an uncontrollable way.10 In the UK, there are around 52,300 new prostate cancer cases each year.10 In certain cases, prostate cancer can grow slowly and may never cause any problems, but in some cases prostate cancer can spread beyond the prostate to other areas of the body.

Lung Cancer occurs when abnormal cells divide in an uncontrollable way to form tumours in the lung or airways.11 There are two main types of lung cancer – non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) – and the main symptoms are a persistent cough, breathlessness, fatigue and weight loss.11 Lung cancer is the third most common cancer in the UK with 47,800 people diagnosed annually.11

Urothelial Cancer or bladder cancer is where tumours develop in the inner lining of the bladder, and in some cases, spreads into the bladder muscle.12 Bladder cancer is commonly separated into slow-growing, non-invasive cancers and fast-growing invasive cancers. Every year over 10,000 people are diagnosed.12

Explore More


Janssen in the UK











1. World Health Organization Regional Office for Europe. Cancer data and statistics. Available at Last accessed May 2022.
2. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356-387.
3. Ogino S. et al. How many molecular subtypes? Implications of the unique tumour principle in personalized medicine. Expert Rev Mol Diagn. 2012; 12(6): 621–628.
4. Myeloma UK. What is myeloma? Available at: Last accessed May 2022.
5. Myeloma UK. Myeloma – An introduction. Available at: Last accessed May 2022.
6. Blood Cancer UK. Chronic lymphocytic leukaemia (CLL). Available at: Last accessed May 2022.
7. Cancer Research UK. What is chronic lymphocytic leukaemia (CLL)?. Available at: Last accessed May 2022.
8. Lymphoma Action. Mantle cell lymphoma. Available at: Last accessed May 2022.
9. WMUK. What is Waldenström’s macroglobulinaemia (WM)? Available at: Last accessed May 2022
10. Cancer Research UK. Prostate cancer incidence. Available at: Last accessed May 2022.
11. Cancer Research UK. About Lung Cancer. Available at: Last accessed May 2022.
12. NHS UK. Bladder cancer. Available at: Last accessed May 2022.

CP-322382 | June 2022